White PL, Springer J, Wise MP, Einsele H, Loeffler C, Seif M, Prommersberger S, Backx M, Loffler J (2022)
Publication Type: Journal article
Publication year: 2022
Book Volume: 8
Article Number: 81
Journal Issue: 1
DOI: 10.3390/jof8010081
The COVID-19 pandemic has resulted in large numbers of patients requiring critical care management. With the established association between severe respiratory virus infection and invasive pulmonary aspergillosis (7.6% for COVID-19-associated pulmonary aspergillosis (CAPA)), the pandemic places a significant number of patients at potential risk from secondary invasive fungal disease. We described a case of CAPA with substantial supporting mycological evidence, highlighting the need to employ strategic diagnostic algorithms and weighted definitions to improve the accuracy in diagnosing CAPA.
APA:
White, P.L., Springer, J., Wise, M.P., Einsele, H., Loeffler, C., Seif, M.,... Loffler, J. (2022). A Clinical Case of COVID-19-Associated Pulmonary Aspergillosis (CAPA), Illustrating the Challenges in Diagnosis (Despite Overwhelming Mycological Evidence). Journal of Fungi, 8(1). https://doi.org/10.3390/jof8010081
MLA:
White, P. Lewis, et al. "A Clinical Case of COVID-19-Associated Pulmonary Aspergillosis (CAPA), Illustrating the Challenges in Diagnosis (Despite Overwhelming Mycological Evidence)." Journal of Fungi 8.1 (2022).
BibTeX: Download